Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReact Group Regulatory News (REAT)

Share Price Information for React Group (REAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 73.50
Bid: 72.00
Ask: 75.00
Change: 0.00 (0.00%)
Spread: 3.00 (4.167%)
Open: 73.50
High: 73.50
Low: 73.50
Prev. Close: 73.50
REAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

7 Mar 2013 07:00

RNS Number : 4123Z
Verdes Management PLC
07 March 2013
 



 

VERDES MANAGEMENT PLC

(AIM: VMP)

 

Preliminary announcement of audited results for the year ended 30 September 2012

 

Verdes Management plc ("Verdes" or "the Company"), the specialist turnaround services provider, is pleased to announce its audited results for the twelve months to 30th September 2012.

 

Chairman's Statement

 

For the year ended 30th September 2012

 

 

I present the financial statements for the year to 30 September, 2012.

 

As we reported in the Interim Results for the six months period to 31st March, 2012, we had increased the efficiency of our business model overall but still faced difficult markets in which to secure a mandate for a turnaround transaction involving a UK plc. The banks remained very reluctant to arrange any new debt funding and equity funding in the City overall remained scarce at a record low. We continued to face the challenges of any start up business and were not able to recruit an additional senior executive to assist in the conversion of some mandates which were in the process of being negotiated.

 

We announced in our Interim Results that we had secured two mandates which were not core to our business model. We were sadly not able to conclude these in large part as a result of the personnel cut back we were required to carry out in the summer which resulted in us having no executive team.

 

We started from the beginning of the calendar year to explore a number of opportunities to bring alongside a complementary business which would benefit from our status on AiM.

 

We took steps in the summer to cut our office overhead drastically and also made sure that there are significant controls on our costs and expenditure. We continued to explore options going forward which we felt were in the interests of our shareholders.

 

Having looked at a number of opportunities, I am pleased to report that we are in the process of completing a financing exercise with certain new investors by which we will, as soon as possible, commence a new business offering which is complementary in the financial services sector.

 

We have announced some of the steps in relation to the above and I look forward to announcing the successful conclusion of these steps.

 

Adam Webb

Chairman

Date: 4 March 2013

 

 

For further information please contact:

Verdes Management plc

www.verdes-group.com

Adam Webb, Chief Executive

+44 (0) 207 839 7284

WH Ireland Limited

www.wh-ireland.co.uk

John Wakefield

+44 (0) 117 945 3470

Verdes Management plc

 

Income Statement

 

For the year ended 30th September 2012

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Note

30 Sep12

 

 

30 Sep 11

 

£

 

£

 

 

 

 

 

Administrative expenses:

(809,039)

(651,246)

 

 

 

 

 

 

Operating profit/(loss)

2

(809,039)

(651,246)

 

 

 

 

 

 

Finance income

6

2,782

16

 

Finance costs

6

-

(17)

 

 

 

 

 

 

Profit/(Loss) on ordinary activities before taxation

(806,257)

(651,247)

 

 

 

 

 

 

Income tax expense

7

-

 

-

 

 

 

 

 

 

Profit/(Loss) for the financial year attributable to equity holders of the company

(806,257)

(651,247)

 

 

 

 

 

Earnings per share for profit/(loss) attributable to the equity holders of the company (pence) on continuing activities

 

 

 

 

 

Basic

8

(0.19)

(0.23)

 

 

 

 

 

 

Diluted

8

(0.19)

(0.23)

 

 

 

The company has no recognised gains or losses other than the results for the

period as set out above.

 

All amounts relate to continuing operations.

Notes 1 to 17 form part of these financial statements.

 

 

 

 

 

 

 

 

 

 

Balance Sheet

 

30th September 2012

 

 

 

Note

30 Sep 12

 

30 Sep 11

Assets

 

£

 

£

Non-current assets

 

 

 

Property, plant and equipment

9

1,418

7,702

Investments

10

500

 

500

1,918

8,202

 

 

 

Current assets

 

 

 

Trade and other receivables

11

16,264

13,922

Cash and cash equivalents

128,196

786,297

 

 

 

 

 

144,460

800,219

 

 

 

 

Total assets

146,378

808,421

 

 

 

 

Liabilities and Equity

 

 

 

Current liabilities

 

 

 

Trade and other payables

12

71,569

34,856

 

 

 

 

Total liabilities

71,569

34,856

 

 

 

 

Equity

 

 

 

Capital and reserves attributable to equity holders of the company

 

 

 

Called-up equity share capital

15

3,158,063

3,121,396

Share premium account

 

2,120,676

2,049,842

Accumulated losses

 

(5,203,930)

(4,397,673)

 

 

 

 

Total Equity

 

74,809

773,565

 

 

 

 

 

Total Liabilities and Equity

 

146,378

808,421

 

 

 

 

 

 

 

These financial statements were approved and authorised for issue by the board and were signed on its behalf by:

 

 

 

 

R A H Webb

Director

 

Date: 4 March 2013

 

 

 

 

 

 

 

 

 

Cash Flow Statement

 

For the year ended 30th September 2012

 

 

 

 

 

 

Note

30 Sep 12

 

 

30 Sep 11

 

 

£

 

£

 

 

 

 

Net cash used in operating activities

16

(767,903)

(729,934)

 

 

 

 

Net cash from investing activities

 

 

 

 

Purchases of property, plant and equipment

 

(481)

(715)

Purchases of listed investments

 

-

(500)

Interest received

 

2,782

16

Interest paid

 

-

(17)

 

 

 

 

Net cash flow before financing activities

 

(765,602)

(731,150)

 

 

 

 

Net cash from financing activities

 

 

 

 

Net proceeds from issue of equity shares

 

107,501

1,390,854

 

 

 

 

Net (decrease)/increase in cash, cash equivalents and overdrafts

 

(658,101)

659,704

 

 

 

 

Cash, cash equivalents and overdrafts at beginning of year

 

786,297

126,593

 

 

 

 

Cash, cash equivalents and overdrafts at end of year

 

128,196

786,297

 

 

 

 

 

 

 

 

Statement of Changes in Equity

 

For the year ended 30th September 2012

 

 

 

 

Share Capital

Share Premium

Retained Earnings

Total Equity

 

 

£

£

£

£

 

Balance at 1/10/10

2,886,921

893,462

(3,746,426)

33,957

 

Issue of ordinary shares

234,475

1,239,773

-

1,474,248

Share issue costs

-

(83,393)

-

(83,393)

Profit/(Loss) for the period

-

-

(651,247)

(651,247)

Balance at 1/10/11

3,121,396

2,049,842

(4,397,673)

773,565

Issue of ordinary shares

36,667

73,333

-

110,000

Share issue costs

-

(2,499)

-

(2,499)

Profit/(Loss) for the period

-

-

(806,257)

(806,257)

 

 

At 30/09/12

3,158,063

2,120,676

(5,203,930)

74,809

 

 

 

 

Notes to the Financial Statements

 

For the year ended 30th September 2012

 

 

1. Accounting policies

 

Basis of accounting

 

The financial statements have been prepared under the historical cost convention and in accordance with International Financial Reporting Standards ("IFRSs") as adopted by the European Union and as applied in accordance with the provisions of Companies Act 2006.

 

Standards and interpretations effective in the current period

 

The following IFRS's which are effective for the first time have been applied in these financial statements. Where adoption is material their effect is detailed below:

 

IAS 24 (revised), 'Related party disclosures' has had no material impact on these financial statements;

• Amendment to IFRS 1, 'First time adoption on fixed dates and hyperinflation' has had no impact on these financial statements;

• Amendment to IFRS 7, 'Financial Instruments: Disclosures - Transfers of Financial Assets'

has had no impact on these financial statements;

• Amendment to IFRIC 14, 'The limit on a defined benefit asset minimum funding requirements and their interaction' has had no impact on these financial statements;

Annual improvements 2010 has had no impact on these financial statements;

New standards and interpretations

 

As of the date of approval of these financial statements, the following Standards and Interpretations which have not been applied in these financial statements were in issue but not yet effective:

 

• IFRS 9 Financial instruments (Effective for periods commencing on or after 1 January 2013);

• IFRS 10 Consolidated financial statements (Effective for periods commencing on or after 1 January 2013);

• IFRS 11 Joint arrangements (Effective for periods commencing on or after 1 January 2013);

• IFRS 12 Disclosure of interests in other entities (Effective for periods commencing on or after 1 January 2013);

• IFRS 13 Fair value measurement (Effective for periods commencing on or after 1 January 2013);

• IAS 27 (Revised) Separate financial statements (Effective for periods commencing on or after 1 January 2013);

• IAS 28 (Revised) Investments in associates and joint ventures (Effective for periods commencing on or after 1 January 2013);

• Amendments to IAS 12: Income taxes: Deferred tax: Recovery of underlying assets (Effective for periods commencing on or after 1 December 2012);

Amendments to IAS 1: 'Presentation of Financial Statements' - Amendments resulting from Annual Improvements 2009-2011 Cycle (Effective for periods commencing on or after 1 January 2013); and

• Amendments to IAS 19, 'Employee benefits' - post-employment benefits and termination benefits projects 1 (Effective for periods commencing on or after 1 January 2013).

 

 

 

 

 

The Directors anticipate that the adoption of these Standards and Interpretations in future periods will have no material impact on the financial statements of the company. The company does not intend to apply any of these pronouncements early.

 

Revenue

 

Revenue is recognised by the company in respect of services supplied during the year, exclusive of Value Added Tax. Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. The following specific recognition criteria must also be met before revenue is recognised:

 

- Management ongoing fees are recognised when the services are rendered.

- Success fees are only recognised when all contractual obligations which determine success are satisfied. 

 

Property, plant and equipment

 

Property, plant and equipment is stated at historical cost less accumulated depreciation and any provision for impairment in value.

 

Depreciation

 

Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows:

 

Fixtures, fittings & equip. - 25% straight line

Motor Vehicles - 25% straight line

Investments

 

Investments held as fixed assets are shown at cost less provision for impairment.

Pensions

 

Contributions to personal pension plans are recognised as an expense when employees have rendered service entitling them to the contributions.

 

Taxation

 

Corporation tax payable is provided on taxable profits at the current rate.

 

Deferred income taxes are calculated using the liability method on temporary differences. This involves the comparison of the carrying amounts of assets and liabilities in the financial statements with their respective tax bases. In addition, tax losses available to be carried forward as well as other income tax credits to the company are assessed for recognition as deferred tax assets. However, deferred tax is not provided on the initial recognition of goodwill, nor on the initial recognition of an asset or liability unless the related transaction is a business combination or affects tax or accounting profit.

 

Deferred tax liabilities are always provided for in full. Deferred tax assets are recognised only to the extent that the directors consider that it is probable that the underlying deductible temporary differences will be able to be offset against future taxable income. Deferred tax is measured on an undiscounted basis at the tax rates that are expected to apply in the periods in which timing differences reverse, based on tax rates and laws enacted or substantively enacted at the balance sheet date.

Financial instruments

 

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

 

Investments

 

All investments are initially recorded at cost, being the fair value of the consideration given and including acquisition costs associated with the investment.

 

Trade and other receivables

 

Trade receivables and other receivables are recognised and carried forward at invoice amounts less provisions for any doubtful debts. Bad debts are written off when identified.

 

Cash and cash equivalents

 

Cash and cash equivalents are included in the balance sheet at cost. Cash and cash equivalents comprise cash at bank and in hand and short term deposits with an original maturity of three months or less.

 

2. Loss on ordinary activities before taxation

 

Loss before taxation is stated after charging:

 

 

30 Sep 12

30 Sep 11

£

£

Depreciation of owned property, plant and equipment

6,765

2,427

 

3. Auditors' remuneration

 

30 Sep 12

30 Sep 11

£

£

Fees payable to the company's auditor for the audit of the

company's annual accounts

8,000

8,000

Fees payable to the company's auditor in respect of:

Other services relating to taxation

1,000

1,000

All other services

1,750

1,750

 

4. Particulars of employees

 

Employee costs, including directors' remuneration, were as follows:

 

 

30 Sep 12

30 Sep 11

£

£

Wages and salaries

377,927

346,191

Social security costs

42,459

30,796

Other pension costs

12,500

13,543

432,886

390,530

 

The average number of staff employed by the company (including directors) during the financial period amounted to:

 

30 Sep 12

30 Sep 11

No.

No.

Number of management staff

7

5

 

5. Directors' Remuneration

 

The directors' aggregate emoluments in respect of qualifying services were:

 

 

30 Sep 12

30 Sep 11

£

£

Emoluments receivable

191,670

252,530

 

2012

Wages & salaries

Pension & other benefits

Fees

Total

£

£

£

£

A E C Edmonstone

22,500

-

-

22,500

J Matthews

26,250

-

-

26,250

R M Phillips

-

-

7,000

7,000

R A H Webb

116,250

19,670

-

135,920

165,000

19,670

7,000

191,670

 

 

 

2011

Wages & salaries

Pension & other benefits

Fees

Total

£

£

£

£

A E C Edmonstone

20,000

-

-

20,000

M D Hosie

-

-

31,015

31,015

J Matthews

23,333

-

-

23,333

R M Phillips

-

-

18,000

18,000

J Rubin

-

-

18,037

18,037

R A H Webb

125,000

17,145

-

142,145

168,333

17,145

67,052

252,530

 

 

 

The highest paid director received remuneration of £135,920 (2011 ‑ £142,145).

 

During the year retirement benefits were accruing to 1 director (2011 - 1 director) in respect of defined contribution pension schemes.

 

6. Finance income and costs

 

30 Sep 12

30 Sep 11

 

£

£

Finance income

Interest income on short term bank deposits

2,782

16

Finance costs

Interest payable on bank overdrafts

-

17

 

 

7. Income tax expense

 

The company has traded at a loss for the current and previous period and has losses brought forward, therefore no provision for taxation was considered necessary.

 

Deferred Tax

 

At the period end the unutilized tax losses carried forward of the company are £1,940,219 (2011: £1,150,669). A deferred tax asset has not been recognised in respect of these losses in view of the uncertainty as to whether these losses are available for set off against future profits. The deferred tax asset that is not recognised in the financial statements in relation to losses carried forward of the company amounts to £389,111 (2011: £230,131).

 

 

 

 

Factors affecting current income tax charge

 

The tax assessed on the loss on ordinary activities for the period is higher than (2011 - higher than) the standard rate of corporation tax in the UK of 20% (2011 - 20.5%).

 

30 Sep 12

30 Sep 11

 

£

£

 

Profit/(Loss) on ordinary activities before taxation

(806,257)

(651,247)

Profit/(loss) on ordinary activities by rate of tax

(161,251)

(133,506)

Expenses not deductible for tax purposes

2,399

2,447

Capital allowances for period in deficit/(excess) of depreciation

939

132

Credit for tax loss not utilised in the accounts

157,913

130,927

Total current tax

-

-

 

8. Earnings per share

 

The basic earnings per ordinary share is calculated by dividing profit/loss for the year attributable to equity holders of the company less non-equity dividends and other appropriations in respect of non-equity shares by the weighted average number of equity shares in issue during the year.

 

The diluted earnings per ordinary share is calculated by dividing profit/loss for the year less non-equity dividends and other appropriations in respect of non-equity shares by the weighted average number of equity shares outstanding during the year (after adjusting both figures for the effect of dilutive potential ordinary shares).

 

The calculation of basic and diluted earnings per ordinary share is based upon the following data:

 

Earnings

30 Sep 12

30 Sep 11

 

£

£

 

Earnings/(loss) for the purposes of basic earnings per share

(806,257)

(651,247)

Earnings/(loss) for the purposes of diluted earnings per share

(806,257)

(651,247)

 

 

Number of shares

30 Sep 12

30 Sep 11

 

No.

No.

 

Basic weighted average number of shares

417,070,536

281,802,743

Dilutive potential ordinary shares:

Adjustment to average number of shares due to share options

-

-

Weighted average number of shares for the purposes of diluted earnings per share

417,070,536

281,802,743

 

9. Property, plant and equipment

30th September 2012

Fixtures, fittings & equipment

Motor Vehicles

Total

 

£

£

Cost

At 1 October 2011

1,884

8,245

10,129

Additions

481

-

481

On disposal

-

-

-

At 30 September 2012

2,365

8,245

10,610

Depreciation

At 1 October 2011

366

2,061

2,427

Charge for the period

581

6,184

6,765

At 30 September 2012

947

8,245

9,192

Net book amount 30 September 2012

1,418

-

1,418

30th September 2011

Fixtures, fittings & equipment

Motor Vehicles

Total

 

£

£

Cost

At 1 October 2010

1,469

8,245

9,714

Additions

715

-

715

On disposal

(300)

-

(300)

At 30 September 2011

1,884

8,245

10,129

Depreciation

At 1 October 2010

-

-

-

Charge for the period

366

2,061

2,427

At 30 September 2011

366

2,061

2,427

Net book amount 30 September 2011

1,518

6,184

7,702

 

10. Investments

 

30th September 2012

Listed investments

 

£

Cost

At 1 October 2011 and 30 September 2012

500

Net book amount 30 September 2012 and 30 September 2011

500

 

Listed investments

 

The fair value of the listed investments at 30 September 2012 was £nil (2011 ‑ £230).

 

11. Trade and other receivables

 

30 Sep 12

30 Sep 11

 

£

£

 

Other receivables

3,364

4,922

Prepayments and accrued income

12,900

9,000

16,264

13,922

 

12. Trade and other payables

 

 

30 Sep 12

30 Sep 11

 

£

£

 

Trade payables

16,284

12,136

Social security and other taxes

10,732

12,760

Other payables

-

1,460

Accruals and deferred income

44,553

8,500

71,569

34,856

 

13. Related party transactions

 

Details of transactions between the company and other related parties are disclosed below.During the period the company was charged £7,000 (2011: £18,000) for directors' services by Prepcare LLP, a limited liability partnership of which R M Phillips is a designated member. At the period end an amount of £nil (2011: £8,266) was payable to Prepcare LLP and is included within trade creditors.

 

14. Share options

 

The directors are interested in the following options to subscribe for ordinary shares pursuant to the directors' share option agreement:

 

R A H Webb

30 Sep 12

30 Sep 11

 

No.

No.

 

Enterprise Management Incentive scheme - granted 12/04/2011

9,663,003

9,663,003

 

The Options are exercisable at a price of £0.01 per £0.001 ordinary share and may be exercised in whole or in part during the period commencing 12 April 2014 to 11 April 2021 subject to achievement of the vesting conditions as established by the Remuneration Committee. No options were exercised in the period. The open market value of the company's shares at the balance sheet date is less than the option price and therefore, R A H Webb is not deemed to have received any share based payment.

 

15. Share capital

 

Authorised share capital:

 

 

30 Sep 12

30 Sep 11

 

£

£

 

785,908,000 Ordinary shares of £0.001 each

785,908

785,908

66,214,920 Deferred 'B' shares of £0.009 each

595,934

595,934

32,938,000 Deferred shares of £0.065 each

2,140,970

2,140,970

3,522,812

3,522,812

 

Allotted, called up and fully paid:

 

 

30 Sep 12

30 Sep 12

30 Sep 11

30 Sep 11

 

No.

£

No.

£

 

Ordinary shares of £0.001 each

420,433,440

420,434

383,766,772

383,767

Deferred 'B' shares of £0.009 each

66,214,920

595,934

66,214,920

595,934

Deferred shares of £0.065 each

32,938,000

2,140,970

32,938,000

2,140,970

519,586,360

3,157,338

482,919,692

3,120,671

 

Allotted, called up and partly paid:

 

 

30 Sep 12

30 Sep 12

30 Sep 11

30 Sep 11

 

No.

£

No.

£

 

Ordinary shares of £0.001 each

7,247,295

725

7,247,295

725

 

The fully paid ordinary £0.001 shares carry one vote per share and carry a right to dividends.The fully paid deferred 'B' shares (£0.009 each) do not carry any votes (other than in a class meeting of the B deferred shares) and have no right to a dividend.

The fully paid deferred shares (£0.065 each) do not carry any votes (other than in a class meeting of the £0.065 deferred shares) and have no right to a dividend.

 

The partly paid ordinary £0.001 shares carry one vote per share and carry a right to dividends. On liquidation of the company, the shareholder acknowledges that the liquidator may require them to pay the balance subscription on any share which has not been paid.

On 12 October 2011, 16,666,667 ordinary shares of 0.1p each were issued at a price of 0.3p per share which were fully paid.

On 3 April 2012, 20,000,000 ordinary shares of 0.1p each were issued at a price of 0.3p per share which were fully paid.

 

Since the year end the Company has issued a further 239,000,000 ordinary shares for a price of 0.1p per share (total consideration of £239,000).

 

16. Cash generated/used by operations

 

 

30 Sep 12

30 Sep 11

 

£

£

 

Profit/(Loss) before taxation

(806,257)

(651,247)

Investment income

(2,782)

(16)

Interest payable

-

17

Loss on disposal of property, plant and equipment

-

300

Depreciation

6,765

2,427

Decrease/(increase) in receivables

(2,342)

2,051

(Decrease)/increase in payables

36,713

(83,466)

Net cash used by operations

(767,903)

(729,934)

 

17. Going Concern

 

In common with other businesses in its sector, the company's results of operations involve a number of risks and uncertainties including, but not limited to, current volatility of the economic environment, developments in strategic relationships and dependence on key individuals or customers. These factors could affect the company's future operating results and cause actual results to vary materially from expectations.

 

The company has generated no revenue in the 12 months to 30th September 2012 and has funded operations from the proceeds of public and private placements of its shares. It does not presently have sufficient funds to meet all of its forecast obligations for the next 12 months and is negotiating with a selection of investors for further funding. Based on discussions already held, the directors of the company have reasonable expectation that the company will receive adequate funding, based on a possible restructuring of the business model along with indications provided by future investors regarding future financing. Accordingly the directors have prepared these accounts on a going concern basis. However whether or not the investors actually provide such funding represents a material uncertainty which casts significant doubt on the company's ability to continue as a going concern and it may be unable to realise its assets and discharge its liabilities in the normal course of business. The financial statements do not include any adjustments that would result if the going concern basis were not appropriate.

 

The Company has no material non-monetary assets or liabilities. In the event that the Going Concern basis no longer applies, no material adjustments to the balance sheet at 30 September 2012 will be required.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR JFMFTMBBMBJJ
Date   Source Headline
25th Apr 20247:00 amRNSTrading Update
16th Apr 202410:00 amRNSHolding(s) in Company
10th Apr 20247:00 amRNSExercise of Warrants & PDMR Dealings
4th Apr 20247:00 amRNSContract Wins
28th Mar 20243:20 pmRNSResult of AGM
28th Mar 20247:00 amRNSAGM Statement
7th Mar 20245:15 pmRNSProposed Share Consolidation Update
6th Mar 20247:00 amRNSProposed Share Consolidation & Notice of AGM
26th Feb 202412:15 pmRNSPresentation at MelloMonday Webinar
13th Feb 20241:45 pmRNSHolding(s) in Company
7th Feb 20245:45 pmRNSHolding(s) in Company
7th Feb 20245:00 pmRNSHolding(s) in Company
6th Feb 20247:00 amRNSFinal Results
5th Feb 20244:30 pmRNSHolding(s) in Company
2nd Feb 20247:00 amRNSNotice of Results & Investor Presentation
15th Jan 20247:00 amRNSAppointment of Joint Broker
14th Dec 20237:00 amRNSExercise of Warrants & PDMR Dealings
12th Dec 20237:00 amRNSBoard Changes
27th Nov 20234:30 pmRNSHolding(s) in Company
22nd Nov 202310:00 amRNSHolding(s) in Company
16th Nov 20237:00 amRNSTrading Update
14th Nov 20233:30 pmRNSHolding(s) in Company
2nd Nov 20233:18 pmRNSHolding(s) in Company
10th Oct 20237:00 amRNSContract Win
13th Sep 20239:50 amRNSHolding(s) in Company
7th Sep 20234:58 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSContract Win
2nd Aug 20237:00 amRNSContract Win
28th Jul 20235:33 pmRNSHolding(s) in Company
28th Jul 202311:04 amRNSHolding(s) in Company
21st Jul 20234:30 pmRNSHolding(s) in Company
19th Jul 20233:48 pmRNSHolding(s) in Company
17th Jul 20232:16 pmRNSHolding(s) in Company
29th Jun 20237:00 amRNSHalf-year Report
20th Jun 20237:00 amRNSInvestor Presentation
24th May 20231:08 pmRNSHolding(s) in Company
22nd May 20237:00 amRNSPresentation at Mello 2023 Investor Conference
15th May 202312:22 pmRNSHolding(s) in Company
24th Apr 20237:00 amRNSTrading Update
17th Apr 20231:07 pmRNSHolding(s) in Company
12th Apr 202312:05 pmRNSPDMR Dealings
11th Apr 202312:45 pmRNSHolding(s) in Company
4th Apr 20234:07 pmRNSHolding(s) in Company
22nd Mar 20232:00 pmRNSHolding(s) in Company
21st Mar 20235:30 pmRNSResult of AGM
21st Mar 20237:00 amRNSAGM Statement
17th Mar 202310:00 amRNSNotice of AGM
13th Feb 20232:22 pmRNSHolding(s) in Company
7th Feb 20237:00 amRNSFinal Results
3rd Feb 20232:02 pmRNSShareholder Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.